Literature DB >> 12584726

Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons.

Toshiyuki Himi1, Masayuki Ikeda, Tadashi Yasuhara, Sei-Itsu Murota.   

Abstract

Glutamate transporters are coupled with cystine/glutamate antiporters to supply cystine as a component of glutathione, an important antioxidant. We sought evidence that L-trans-pyrrolidine-2,4-dicarboxylate (PDC) enhances glutamate-induced neuronal damage not only via the N-methyl-D-aspartate (NMDA) receptor mediated pathway, but also through induction of oxidative stress. Cultured hippocampal cells were exposed to glutamate (100 microM) for 5 min, washed and incubated for 18 hr with PDC (200 microM). PDC, increasing the neuronal death to 147% of that induced by glutamate alone, depleted glutathione in the culture, and produced dichloro-dihydro-fluorescein-diacetate-positive reactive oxygen species in neurons. N-acetylcysteine (2 mM) not only reduced PDC-enhanced neuronal death but also recovered glutathione and abolished the reactive oxygen species in these neurons. Threo-beta-benzyloxyaspartate, another type of glutamate transporter inhibitor, also induced glutathione depletion in the glutamate-preloaded cells, suggesting the involvement of glutamate transporter blocking in glutathione depletion. The NMDA receptor antagonist MK-801, although partially effective in reducing PDC toxicity, slightly recovered glutathione level but did not reduce the reactive oxygen species even at a high concentration (100 microM). N-acetylcysteine, dimethylsulfoxide, alpha-phenyl-N-butyl nitrone and glutathione ethylester prevented neuronal death enhanced by PDC, but superoxide dismutase and catalase did not. Our study provides evidence that the block of glutamate uptake by PDC exerts toxicity on glutamate-pretreated neurons not only through the accumulation of extracellular glutamate and subsequent activation of the NMDA receptor but also through depletion of glutathione and generation of reactive oxygen species. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584726     DOI: 10.1002/jnr.10510

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  10 in total

1.  A sublethal dose of TNFalpha potentiates kainate-induced excitotoxicity in optic nerve oligodendrocytes.

Authors:  Brandon A Miller; Fang Sun; Randolph N Christensen; Adam R Ferguson; Jacqueline C Bresnahan; Michael S Beattie
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

2.  Glutamatergic modulation of auditory information processing in the human brain.

Authors:  Handan Gunduz-Bruce; Robert M G Reinhart; Brian J Roach; Ralitza Gueorguieva; Stephen Oliver; Deepak C D'Souza; Judith M Ford; John H Krystal; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2011-10-29       Impact factor: 13.382

3.  Protective effects of N-acetylcysteine on noise-induced hearing loss in guinea pigs.

Authors:  A R Fetoni; M Ralli; B Sergi; C Parrilla; D Troiani; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-04       Impact factor: 2.124

4.  High glutamate attenuates S100B and LDH outputs from rat cortical slices enhanced by either oxygen-glucose deprivation or menadione.

Authors:  Celaleddin Demircan; Zülfiye Gül; R Levent Büyükuysal
Journal:  Neurochem Res       Date:  2014-04-08       Impact factor: 3.996

Review 5.  N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.

Authors:  Olivia Dean; Frank Giorlando; Michael Berk
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

6.  Clinical translational neuroimaging of the antioxidant effect of N-acetylcysteine on neural microstructure.

Authors:  Sue Y Yi; Brian R Barnett; McKenzie J Poetzel; Nicholas A Stowe; John-Paul J Yu
Journal:  Magn Reson Med       Date:  2021-09-30       Impact factor: 4.668

Review 7.  Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation.

Authors:  Osama A Abulseoud; Fawaz Alasmari; Abdelaziz M Hussein; Youssef Sari
Journal:  Front Neurosci       Date:  2022-07-05       Impact factor: 5.152

8.  Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.

Authors:  Hyesook Yoon; Maja Radulovic; Jianmin Wu; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neurochem       Date:  2013-05-27       Impact factor: 5.372

9.  Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway.

Authors:  Xin-long Huo; Jing-jing Min; Cai-yu Pan; Cui-cui Zhao; Lu-lu Pan; Fei-fei Gui; Lu Jin; Xiao-tong Wang
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

10.  Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats.

Authors:  Abeer M Aldbass; Ramesa Shafi Bhat; Afaf El-Ansary
Journal:  J Neuroinflammation       Date:  2013-03-27       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.